Recent Updates
Recently added Catalysts
GNLX Positive Sentiment Score: 70/100

Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit

Wednesday, October 9, 2024 1 min read
Key Takeaway: Genelux Corporation (NASDAQ: GNLX) announced that its President and CEO, Thomas Zindrick, will participate in the upcoming 2024 Maxim Healthcare Virtual Summit from October 15-17, 2024. During the summit, Zindrick is set to engage in a fireside chat focusing on the company's clinical-stage programs and recent developments. This event represents a significant opportunity for Genelux to showcase its advancements in immuno-oncology.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prominent healthcare summit demonstrates company visibility.
  • Opportunity to discuss clinical programs and future milestones can attract investor interest.

Full Press Release Details

WESTLAKE VILLAGE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board, will participate at the 2024 Maxim Healthcare Virtual Summit taking place October 15-17, 2024.
Mr. Zindrick will discuss clinical-stage programs, recent announcements, and upcoming milestones in a fireside chat with Jason McCarthy, Ph.D., Senior Managing Director, Head of Biotechnology Research, which is scheduled for 2:00 pm E.T. on October 15, 2024.
About Genelux Corporation
Investor and Media Contacts
Allele Communications, LLC
genelux@allelecomms.com
Source: Genelux Corporation

Tags

Frequently Asked Questions

What event will Thomas Zindrick participate in?

Thomas Zindrick will attend the 2024 Maxim Healthcare Virtual Summit.

When is the virtual summit taking place?

The summit is scheduled from October 15 to 17, 2024.

What topics will Mr. Zindrick discuss?

He will talk about clinical-stage programs and upcoming milestones.

Who will Mr. Zindrick have a fireside chat with?

He will chat with Jason McCarthy, Ph.D., on October 15.

What is Genelux Corporation focused on?

Genelux Corporation is focused on immuno-oncology.

Tags: GNLX Viatris Investor Conferences Healthcare Genelux Corporation healthcare summit immuno-oncology clinical programs
Last updated: Oct 9, 2024